Jazz Pharmaceuticals (JAZZ) in Focus: Stock Surges 8.8%
Jazz Pharmaceuticals Public Limited Company (JAZZ) was a big mover last session, as the company saw its shares rise nearly 9% on the day. This jump can be attributable to solid volume too with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $132.55 to $153.48 in the past one-month time frame, showed a pick-up yesterday at $144.23.
The company has seen 1 estimate revision over the past 30 days and its Zacks Consensus Estimate moved higher over the same time period, suggesting that more solid trading could be ahead for Jazz. So make sure to keep an eye on this stock going forward to see if yesterday’s gain can turn into more strength down the road.
Jazz Pharmaceuticals currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Other better ranked biotechnology stocks include Endo International plc (ENDP), Hyperion Therapeutics, Inc. (HPTX) and PharmAthene, Inc. (PIP) all carrying a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
JAZZ PHARMACEUTICALS PLC IRELAND (JAZZ): Free Stock Analysis Report
ENDO INTERNATIONAL PLC ORD (ENDP): Free Stock Analysis Report
HYPERION THERAPEUTICS INC (HPTX): Free Stock Analysis Report
PHARMATHENE INC (PIP): Free Stock Analysis Report
Zacks Investment Research